Physician profile
Saeed Bashir
NPI 1336408020
$8,316.37
in general payments reported to CMS, 2019-2025
14 companies · $584 in 2025
The $584 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,371 · 2020: $1,201 · 2021: $1,762 · 2022: $1,248 · 2023: $150 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $733.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,026.17 | 2019-2025 | Indigo System |
| Abbott Laboratories | $1,887.06 | 2019 | |
| Boston Scientific Corporation | $971.62 | 2020-2025 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), General - Embolics |
| Medtronic, INC. | $811.48 | 2021-2025 | Hawkone, Turbohawk |
| Medtronic Vascular, INC. | $775.88 | 2019-2020 | |
| Inari Medical, INC. | $234.99 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $206.42 | 2025 | Spinejack, Augment Injectable |
| Cook Medical LLC | $115.42 | 2020 | |
| Endologix LLC | $84.70 | 2020 | |
| Sirtex Medical INC | $81.90 | 2019 | |
| Ge Healthcare | $45.86 | 2021 | |
| Avanos Medical | $32.03 | 2021 | |
| Angiodynamics, INC. | $25.17 | 2020-2023 | Bioflo |
| Terumo Medical Corporation | $17.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saeed Bashir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.